Abstract
Purpose
Diabetic peripheral neuropathy (DPN), a common microvascular complication of diabetes, is linked to glycaemic derangements. Glycaemic variability, as a pattern of glycaemic derangements, is a key risk factor for diabetic complications. We investigated the association of glycaemic variability with DPN in a large-scale sample of type 2 diabetic patients.
Methods
In this cross-sectional study, we enrolled 982 type 2 diabetic patients who were screened for DPN and monitored by a continuous glucose monitoring (CGM) system between February 2011 and January 2017. Multiple glycaemic variability parameters, including the mean amplitude of glycaemic excursions (MAGE), mean of daily differences (MODD), standard deviation of glucose (SD), and 24-h mean glucose (24-h MG), were calculated from glucose profiles obtained from CGM. Other possible risks for DPN were also examined.
Results
Of the recruited type 2 diabetic patients, 20.1% (n = 197) presented with DPN, and these patients also had a higher MAGE, MODD, SD, and 24-h MG than patients without DPN (p < 0.001). Using univariate and multiple logistic regression analyses, MAGE and conventional risks including diabetic duration, HOMA-IR, and hemoglobin A1c (HbA1c) were found to be independent contributors to DPN, and the corresponding odds ratios (95% confidence interval) were 4.57 (3.48–6.01), 1.10 (1.03–1.17), 1.24 (1.09–1.41), and 1.33 (1.15–1.53), respectively. Receiver operating characteristic analysis indicated that the optimal MAGE cutoff value for predicting DPN was 4.60 mmol/L; the corresponding sensitivity was 64.47%, and the specificity was 75.54%.
Conclusions
In addition to conventional risks including diabetic duration, HOMA-IR and HbA1c, increased glycaemic variability assessed by MAGE is a significant independent contributor to DPN in type 2 diabetic patients.
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- SBP:
-
Systolic blood pressure
- DBP:
-
Diastolic blood pressure
- TC:
-
Total cholesterol
- TG:
-
Triglyceride
- HDLC:
-
High-density lipoprotein cholesterol
- LDLC:
-
Low-density lipoprotein cholesterol
- FPG:
-
Fasting plasma glucose
- Serum UA:
-
Serum uric acid
- HOMA-IR:
-
Insulin resistance estimated by the HOMA model
- HbA1c:
-
Glycosylated hemoglobin A1c
- MAGE:
-
Mean amplitude of glycaemic excursions
- MODD:
-
Mean of daily differences
- SD:
-
Standard deviation of glucose
- 24-h MG:
-
24-h Mean glucose
References
P.R.J. Vas, M.E. Edmonds, Early recognition of diabetic peripheral neuropathy and the need for one-stop microvascular assessment. Lancet Diabetes Endocrinol. 4(9), 723–725 (2016). https://doi.org/10.1016/s2213-8587(16)30063-8
B.C. Callaghan, H.T. Cheng, C.L. Stables, A.L. Smith, E.L. Feldman, Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 11(6), 521–534 (2012). https://doi.org/10.1016/s1474-4422(12)70065-0
R. Pop-Busui, J. Lu, M.M. Brooks, S. Albert, A.D. Althouse, J. Escobedo, J. Green, P. Palumbo, B.A. Perkins, F. Whitehouse, T.L. Jones, Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) cohort. Diabetes Care 36(10), 3208–3215 (2013). https://doi.org/10.2337/dc13-0012
L. Monnier, C. Colette, D.R. Owens, Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept. Diabetes Metab. Res. Rev. 25(5), 393–402 (2009). https://doi.org/10.1002/dmrr.962
N.R. Hill, N.S. Oliver, P. Choudhary, J.C. Levy, P. Hindmarsh, D.R. Matthews, Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups. Diabetes Technol. Ther. 13(9), 921–928 (2011). https://doi.org/10.1089/dia.2010.0247
C. Colette, L. Monnier, Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes. Horm. Metab. Res. 39(9), 683–686 (2007). https://doi.org/10.1055/s-2007-985157
G. Sartore, N.C. Chilelli, S. Burlina, A. Lapolla, Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes. Acta Diabetol. 50(3), 437–442 (2013). https://doi.org/10.1007/s00592-013-0459-9
F. Xu, L.H. Zhao, J.B. Su, T. Chen, X.Q. Wang, J.F. Chen, G. Wu, Y. Jin, X.H. Wang, The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c. Diabetol. Metab. Syndr. 6(1), 139 (2014). https://doi.org/10.1186/1758-5996-6-139
H.Y. Jin, K.A. Lee, T.S. Park, The impact of glycemic variability on diabetic peripheral neuropathy. Endocrine 53(3), 643–648 (2016). https://doi.org/10.1007/s12020-016-1005-7
American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 34(Suppl 1), S62–S69 (2011). Doi:10.2337/dc11-S062.
S. Tesfaye, A.J. Boulton, P.J. Dyck, R. Freeman, M. Horowitz, P. Kempler, G. Lauria, R.A. Malik, V. Spallone, A. Vinik, L. Bernardi, P. Valensi, Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33(10), 2285–2293 (2010). https://doi.org/10.2337/dc10-1303
Chinese Diabetes Society, Chinese clinical guideline for continuous glucose monitoring (2012). Chin. Med. J. 125(23), 4167–4174 (2012). https://doi.org/10.3760/cma.j.issn.0366-6999.2012.23.002
D. Rodbard, New and improved methods to characterize glycemic variability using continuous glucose monitoring. Diabetes Technol. Ther. 11(9), 551–565 (2009). https://doi.org/10.1089/dia.2009.0015
F.J. Service, Glucose variability. Diabetes 62(5), 1398–1404 (2013). https://doi.org/10.2337/db12-1396
M. Ohara, T. Fukui, M. Ouchi, K. Watanabe, T. Suzuki, S. Yamamoto, T. Yamamoto, T. Hayashi, K. Oba, T. Hirano, Relationship between daily and day-to-day glycemic variability and increased oxidative stress in type 2 diabetes. Diabetes Res. Clin. Pract. 122, 62–70 (2016). https://doi.org/10.1016/j.diabres.2016.09.025
A. Ceriello, M.A. Ihnat, ‘Glycaemic variability’: a new therapeutic challenge in diabetes and the critical care setting. Diabet. Med. 27(8), 862–867 (2010). https://doi.org/10.1111/j.1464-5491.2010.02967.x
L. Monnier, E. Mas, C. Ginet, F. Michel, L. Villon, J.P. Cristol, C. Colette, Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295(14), 1681–1687 (2006). https://doi.org/10.1001/jama.295.14.1681
K. Torimoto, Y. Okada, H. Mori, Y. Tanaka, Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus. Cardiovasc. Diabetol. 12, 1 (2013). https://doi.org/10.1186/1475-2840-12-1
P.S. Dasari, B.S. Gandomani, A.M. Teague, A. Pitale, M. Otto, K.R. Short, Glycemic variability is associated with markers of vascular stress in adolescents. J. Pediatr. 172, 47–55 e42 (2016). https://doi.org/10.1016/j.jpeds.2016.01.065
G. Su, S. Mi, H. Tao, Z. Li, H. Yang, H. Zheng, Y. Zhou, C. Ma, Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes. Cardiovasc. Diabetol. 10, 19 (2011). https://doi.org/10.1186/1475-2840-10-19
G. Su, S.H. Mi, H. Tao, Z. Li, H.X. Yang, H. Zheng, Y. Zhou, L. Tian, Impact of admission glycemic variability, glucose, and glycosylated hemoglobin on major adverse cardiac events after acute myocardial infarction. Diabetes Care 36(4), 1026–1032 (2013). https://doi.org/10.2337/dc12-0925
C.M. Chang, C.J. Hsieh, J.C. Huang, I.C. Huang, Acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitus. Acta Diabetol. 49(Suppl 1), S171–177 (2012). https://doi.org/10.1007/s00592-012-0398-x
C. Gorst, C.S. Kwok, S. Aslam, I. Buchan, E. Kontopantelis, P.K. Myint, G. Heatlie, Y. Loke, M.K. Rutter, M.A. Mamas, Long-term glycemic variability and risk of adverse outcomes: a systematic review and meta-analysis. Diabetes Care 38(12), 2354–2369 (2015). https://doi.org/10.2337/dc15-1188
A.O. Luk, R.C. Ma, E.S. Lau, X. Yang, W.W. Lau, L.W. Yu, F.C. Chow, J.C. Chan, W.Y. So, Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry. Diabetes Metab. Res. Rev. 29(5), 384–390 (2013). https://doi.org/10.1002/dmrr.2404
J.E. Jun, S.M. Jin, J. Baek, S. Oh, K.Y. Hur, M.S. Lee, M.K. Lee, J.H. Kim, The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes. Cardiovasc. Diabetol. 14, 70 (2015). https://doi.org/10.1186/s12933-015-0233-0
C.C. Lin, C.C. Chen, F.N. Chen, C.I. Li, C.S. Liu, W.Y. Lin, S.Y. Yang, C.C. Lee, T.C. Li, Risks of diabetic nephropathy with variation in hemoglobin A1c and fasting plasma glucose. Am. J. Med. 126(11), 1017. e1011–1010 (2013). https://doi.org/10.1016/j.amjmed.2013.04.015
C.C. Lin, C.P. Yang, C.I. Li, C.S. Liu, C.C. Chen, W.Y. Lin, K.L. Hwang, S.Y. Yang, T.C. Li, Visit-to-visit variability of fasting plasma glucose as predictor of ischemic stroke: competing risk analysis in a national cohort of Taiwan Diabetes Study. BMC Med. 12, 165 (2014). https://doi.org/10.1186/s12916-014-0165-7
H.T. Chiu, T.C. Li, C.I. Li, C.S. Liu, W.Y. Lin, C.C. Lin, Visit-to-visit glycemic variability is a strong predictor of chronic obstructive pulmonary disease in patients with type 2 diabetes mellitus: Competing risk analysis using a national cohort from the Taiwan diabetes study. PLoS One 12(5), e0177184 (2017). https://doi.org/10.1371/journal.pone.0177184
T.C. Li, C.P. Yang, S.T. Tseng, C.I. Li, C.S. Liu, W.Y. Lin, K.L. Hwang, S.Y. Yang, J.H. Chiang, C.C. Lin, Visit-to-visit variations in fasting plasma glucose and HbA1c associated with an increased risk of alzheimer disease: Taiwan Diabetes Study. Diabetes Care 40(9), 1210–1217 (2017). https://doi.org/10.2337/dc16-2238
J.I. Chiang, T.C. Li, C.I. Li, C.S. Liu, N.H. Meng, W.Y. Lin, S.Y. Yang, H.J. Chen, C.C. Lin, Visit-to-visit variation of fasting plasma glucose is a predictor of hip fracture in older persons with type 2 diabetes: the Taiwan Diabetes Study. Osteoporos. Int. 27(12), 3587–3597 (2016). https://doi.org/10.1007/s00198-016-3689-1
C.C. Lin, C.I. Li, C.S. Liu, W.Y. Lin, C.C. Chen, S.Y. Yang, C.C. Lee, T.C. Li, Annual fasting plasma glucose variation increases risk of cancer incidence and mortality in patients with type 2 diabetes: the Taichung Diabetes Study. Endocr. Relat. Cancer 19(4), 473–483 (2012). https://doi.org/10.1530/erc-12-0038
C.C. Lin, C.I. Li, S.Y. Yang, C.S. Liu, C.C. Chen, M.M. Fuh, W. Chen, T.C. Li, Variation of fasting plasma glucose: a predictor of mortality in patients with type 2 diabetes. Am. J. Med. 125(4), 416. e419–418 (2012). https://doi.org/10.1016/j.amjmed.2011.07.027
P. Katulanda, P. Ranasinghe, R. Jayawardena, G.R. Constantine, M.H. Sheriff, D.R. Matthews, The prevalence, patterns and predictors of diabetic peripheral neuropathy in a developing country. Diabetol. Metab. Syndr. 4(1), 21 (2012). https://doi.org/10.1186/1758-5996-4-21
J.C. Won, H.S. Kwon, C.H. Kim, J.H. Lee, T.S. Park, K.S. Ko, B.Y. Cha, Prevalence and clinical characteristics of diabetic peripheral neuropathy in hospital patients with Type 2 diabetes in Korea. Diabet. Med. 29(9), e290–296 (2012). https://doi.org/10.1111/j.1464-5491.2012.03697.x
D. Selvarajah, I.D. Wilkinson, C.J. Emery, N.D. Harris, P.J. Shaw, D.R. Witte, P.D. Griffiths, S. Tesfaye, Early involvement of the spinal cord in diabetic peripheral neuropathy. Diabetes Care 29(12), 2664–2669 (2006). https://doi.org/10.2337/dc06-0650
C. Clair, M.J. Cohen, F. Eichler, K.J. Selby, N.A. Rigotti, The effect of cigarette smoking on diabetic peripheral neuropathy: a systematic review and meta-analysis. J. Gen. Intern. Med 30(8), 1193–1203 (2015). https://doi.org/10.1007/s11606-015-3354-y
X. Qiao, H. Zheng, S. Zhang, S. Liu, Q. Xiong, F. Mao, Z. Zhang, J. Wen, H. Ye, Y. Li, B. Lu, C-peptide is independent associated with diabetic peripheral neuropathy: a community-based study. Diabetol. Metab. Syndr. 9, 12 (2017). https://doi.org/10.1186/s13098-017-0208-2
E.S. Kim, S.W. Lee, E.Y. Mo, S.D. Moon, J.H. Han, Inverse association between serum total bilirubin levels and diabetic peripheral neuropathy in patients with type 2 diabetes. Endocrine 50(2), 405–412 (2015). https://doi.org/10.1007/s12020-015-0583-0
Y. Hu, F. Liu, J. Shen, H. Zeng, L. Li, J. Zhao, J. Zhao, F. Lu, W. Jia, Association between serum cystatin C and diabetic peripheral neuropathy: a cross-sectional study of a Chinese type 2 diabetic population. Eur. J. Endocrinol. 171(5), 641–648 (2014). https://doi.org/10.1530/eje-14-0381
R. He, Y. Hu, H. Zeng, J. Zhao, J. Zhao, Y. Chai, F. Lu, F. Liu, W. Jia, Vitamin D deficiency increases the risk of peripheral neuropathy in Chinese patients with type 2 diabetes. Diabetes Metab. Res. Rev. 33(2), e2820 (2017). https://doi.org/10.1002/dmrr.2820
W. Zhao, H. Zeng, X. Zhang, F. Liu, J. Pan, J. Zhao, J. Zhao, L. Li, Y. Bao, F. Liu, W. Jia, A high thyroid stimulating hormone level is associated with diabetic peripheral neuropathy in type 2 diabetes patients. Diabetes Res. Clin. Pract. 115, 122–129 (2016). https://doi.org/10.1016/j.diabres.2016.01.018
S. Yu, Y. Chen, X. Hou, D. Xu, K. Che, C. Li, S. Yan, Y. Wang, B. Wang, Serum uric acid levels and diabetic peripheral neuropathy in type 2 diabetes: a systematic review and meta-analysis. Mol. Neurobiol. 53(2), 1045–1051 (2016). https://doi.org/10.1007/s12035-014-9075-0
Y. Zhang, Y. Jiang, X. Shen, S. Yan, Can both normal and mildly abnormal albuminuria and glomerular filtration rate be a danger signal for diabetic peripheral neuropathy in type 2 diabetes mellitus? Neurol. Sci. 38(8), 1381–1390 (2017). https://doi.org/10.1007/s10072-017-2946-1
A. Tentolouris, I. Eleftheriadou, P. Grigoropoulou, A. Kokkinos, G. Siasos, I. Ntanasis-Stathopoulos, N. Tentolouris, The association between pulse wave velocity and peripheral neuropathy in patients with type 2 diabetes mellitus. J. Diabetes Complicat. 31(11), 1624–1629 (2017). https://doi.org/10.1016/j.jdiacomp.2017.07.010
S. Liu, H. Zheng, X. Zhu, F. Mao, S. Zhang, H. Shi, Y. Li, B. Lu, Neutrophil-to-lymphocyte ratio is associated with diabetic peripheral neuropathy in type 2 diabetes patients. Diabetes Res. Clin. Pract. 130, 90–97 (2017). https://doi.org/10.1016/j.diabres.2017.05.008
T. Zhu, Q. Meng, J. Ji, X. Lou, L. Zhang, Toll-like receptor 4 and tumor necrosis factor-alpha as diagnostic biomarkers for diabetic peripheral neuropathy. Neurosci. Lett. 585, 28–32 (2015). https://doi.org/10.1016/j.neulet.2014.11.020
C. Herder, I. Schamarek, B. Nowotny, M. Carstensen-Kirberg, K. Strassburger, P. Nowotny, J.M. Kannenberg, A. Strom, S. Puttgen, K. Mussig, J. Szendroedi, M. Roden, D. Ziegler, Inflammatory markers are associated with cardiac autonomic dysfunction in recent-onset type 2 diabetes. Heart 103(1), 63–70 (2017). https://doi.org/10.1136/heartjnl-2015-309181
M. Brownlee, Biochemistry and molecular cell biology of diabetic complications. Nature 414(6865), 813–820 (2001). https://doi.org/10.1038/414813a
Funding
The study was funded by the Scientific Research Program of Nantong (HS2012028 and MS22015065), the Scientific Research Program of Health and Planning Commission of Jiangsu (H201553) and the Scientific and Educational Program for Prosperity of Health Care of Jiangsu (QNRC2016408).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This study strictly adhered to the principles of the Helsinki Declaration and was approved by the Medical Ethics Committee of Nantong University.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Hu, Ym., Zhao, Lh., Zhang, Xl. et al. Association of glycaemic variability evaluated by continuous glucose monitoring with diabetic peripheral neuropathy in type 2 diabetic patients. Endocrine 60, 292–300 (2018). https://doi.org/10.1007/s12020-018-1546-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-018-1546-z